Table 2.
Concentrations of the J2-2P~J2-3 and the J2-3 sequences measured by digital PCR and the ratios (J2-2P~J2-3 to J2-3) for TCL and non-TCL patients.
| Individual | J2-2P~J2-3 (copies/ul) | J2-3 (copies/ul) | ratio (%) | BIOMED-2 test |
|---|---|---|---|---|
| TCL1 | 2.6 | 9.7 | 26.6 | TCRγ: monoclonal; TCRβ: polyclonal |
| TCL2 | 11.5 | 83.3 | 13.8 | TCRγ: monoclonal; TCRβ: polyclonal |
| TCL3 | 5.0 | 50.6 | 10.0 | TCRγ: monoclonal; TCRβ: polyclonal |
| TCL4 | 4.9 | 21.9 | 22.5 | TCRγ: monoclonal; TCRβ: polyclonal |
| TCL5 | 8.2 | 16.8 | 48.7 | TCRγ: polyclonal; TCRβ: polyclonal |
| TCL6 | 1.0 | 3.1 | 31.1 | TCRγ: polyclonal; TCRβ: polyclonal |
| TCL7 | 12.7 | 225.6 | 5.6 | TCRγ: polyclonal; TCRβ: polyclonal |
| TCL8 | 23.0 | 261.8 | 8.8 | TCRγ: polyclonal; TCRβ: polyclonal |
| TCL9 | 2.6 | 30.5 | 8.6 | TCRγ: polyclonal; TCRβ: polyclonal |
| Non-TCL1 | 8.6 | 398.0 | 2.2 | N.A. |
| Non-TCL2 | 8.2 | 405.5 | 2.0 | N.A. |
| Non-TCL3 | 3.3 | 158.3 | 2.1 | N.A. |
| Non-TCL4 | 33.8 | 793.8 | 4.3 | N.A. |
| Non-TCL5 | 2.6 | 79.3 | 3.3 | N.A. |
| Non-TCL6 | 2.8 | 80.6 | 3.6 | N.A. |
NA, Not applicable.